| INTRODUCTION
Body fluid analysis is a routine laboratory test that provides valuable information to clinicians for the diagnosis and management of several diseases, such as spontaneous bacterial peritonitis in patients with peritoneal dialysis or cirrhosis 1 since peritonitis remains a leading complication of peritoneal dialysis. 2 Moreover, it is the most rapid and cost-effective method to investigate the probable cause of ascites 3 and may be useful in pleural effusion classification.
4,5
Manual microscopy is still considered the gold standard for evaluation and classification of cells in body fluids, 6 but may be a challenging and time consuming process in laboratories of referral hospitals, especially if a large number of biological fluids are received and shortage of skilled personnel occurs. Some drawbacks include manual performance along with inter-observer variability, high imprecision, and high inaccuracy, especially if performed by less trained personnel.
Therefore, different automated hematology analyzers have developed additional modes for body fluid cell count, which may be an alternative to microscopic examination to obtain faster and accurate results for clinical decision-making. Some of these automated cell counters have been validated with different body fluid specimens to determine white blood cell (WBC) or total nucleated cell (TNC) count, but very few studies analyze differential cell count. [7] [8] [9] [10] [11] [12] One of the most recently launched hematology analyzer with body fluid (BF) mode is Mindray BC-6800 (Mindray Bio-medical Electronics Co., Ltd., Shenzhen, China;
hereinafter called BC-6800). To our knowledge, there are no published articles focused in the analysis of continuous ambulatory peritoneal dialysis (CAPD) body fluids with BC-6800. In addition, there is limited information regarding the performance evaluation of BC-6800 with other body fluids. 13, 14 Therefore, the aim of this study was to assess the BC-6800 analyzer performance for WBC and differential cell count in CAPD, ascitic, and pleural body fluids compared with manual microscopy.
| MATERIALS AND METHODS

| BC-6800 BF mode
The BF mode provides WBC and differential cell count, RBC count 
| Patient samples
The study was carried out with 150 body fluid samples from 49 female and 101 male patients (median age: 57 years; range: 1-97 years):
50 CAPD, 60 ascitic, and 40 pleural body fluids from hospital wards and peritoneal dialysis outpatients. Patients included in this study had a broad spectrum of diseases [e.g. CAPD fluids were recruited from patients with chronic kidney disease (n=50); ascitic body fluids were recruited from patients with hepatitis c virus cirrhosis (n=34), alcoholic cirrhosis (n=15), oncologic (n=6), and miscellanea (n=5) diseases; pleural body fluids were recruited from patients with pneumonia (n=12), congestive heart failure (n=8), oncologic (n=5), and miscellanea (n=15) diseases]. All samples were collected in 2.0 mL K2 EDTA tubes, sent to the laboratory for routine diagnostic purposes and microscopic cell count. The specimen leftover was mixed by gentle inversion 6-8 times, and was further subjected to automated analysis by BC-6800
and microscopic evaluation within 4 hours of sampling. The study was carried out in accordance with the Declaration of Helsinki and was in line with any relevant local legislation.
| Method comparison analysis
The method comparison analysis of WBC and differential cell count was performed between the automated BF mode of BC-6800 and microscopic examination. Manual microscopic WBC count was performed using the Fuchs-Rosenthal chamber (surface area 16 mm 2 and depth 0.2 mm). The Fuchs-Rosenthal manual counting chamber was covered with a thin glass coverslide and body fluids were filled with no air bubbles into the chamber using a pipette. 
| BC-6800 performance evaluation
The within-run precision for WBC cell count was determined with BC-6800 by measuring nine body fluid samples of different cell concentrations for a minimum of five times depending on the available volume. The coefficient of variation (CV) at the expected counts was calculated.
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The limit of blank (LoB) described by the BC-6800 manufacturer was verified by running 20 measurements of cell-free body fluids (n=3), which have been previously evaluated in the counting chamber.
The limit of detection (LoD) was determined by measuring 10 consecutive times low-cell concentration body fluids (n=6), for a total of 60 results. All samples were within the range of four times the LoB.
The LoD was determined according to the formula: LoD=LoB+1.645 *SD. 16 The limit of quantitation (LoQ) was determined mathematically by the power regression equation, which was obtained from the plot between WBC count and the CV from the precision study. The LoQ was defined as the lowest cell concentration that can be measured with 95% confidence of a CV of 20%.
The WBC count carryover was verified by running a peritoneal fluid with a high count (A1, A2, A3) three consecutive times, followed by a peritoneal sample with a low cell count (B1, B2, B3). The results
were calculated according to the formula
: carryover %=(B1-B3)/ (A2-B3)×100.
| Statistics
The results of the method comparison between the automated analysis by BC-6800 and the manual microscopy for body fluid cell count were assessed by Passing and Bablok regression (interchambiability criteria were 95%CI of the slope including the 1 and the intercept including the 0), Wilcoxon signed-rank paired test and Kappa agreement.
Bias (and 95%CI) was calculated with the Bland-Altman analysis.
Sensibility, specificity, and diagnostic concordance with receiver operating characteristic curves (ROC) were calculated for BC-6800 and then compared to manual microscopy. The statistical evaluation results were processed with the Statistical Package of Social Sciences (version 15.0; Chicago, IL, USA) for Windows.
| RESULTS
One hundred and fifty body fluids (50 CAPD, 60 ascitic, 40 pleural)
were received over a 2-month study period. Five ascitic body fluid samples with high cell count results outside analytical measuring range were excluded, so 145 samples were included in the statistical analysis. Differential cell count was performed in 72 samples with WBC count higher than 100 cells/μL.
| Comparison results of the WBC, MN, and PMN count in all body fluids
The WBC count for all the body fluids ranged from 1 to 9360 cells/ μL. The median WBC count values presented no significant statistical differences between both methods ( Table 1 (Table 1 and Figure 1 ).
The MN differential cell count results were similar to the WBC results, with no significant statistical differences between both methods (Table 1 and Figure 1 ). However, the PMN result showed significant statistical differences in the median cell count and Passing-Bablok regression: y=1.21x+13.37 (95% CI of slope 1.03 to 1.35; and intercept 4.00 to 32.47; Table 1 and Figure 1 ). The Bland-Altman analysis confirmed that bias was present with a mean difference of 78 PMN/μL ( of 0.70 (95%CI: 0.38 to 1.00) and we found three discrepant results (Table 2) . One patient with spontaneous bacterial peritonitis was misclassified as negative by manual microscopy. The other two samples were classified as positive by the BC-6800 and corresponded to ascitic decompensation in oncologic patients.
| Performance results
The within-run precision was examinated for WBC count compressed between 2 and 2909 cells/μL. The CV obtained ranged between 3%
and 34% (Table 3 ).
The LoB claimed by the manufacturer (3 cell/μL) was confirmed.
This result implies a LoD of 8 cells/μL. The LoQ was 8 cells/μL
( Figure 2 ). Carryover was verified and never exceeded 0.05%, which was lower than the established by the manufacturer.
| DISCUSSION
In the present study, we compared the automatic cellular analysis of different types of body fluids in a recently launched hematology analyzer (Mindray BC-6800) with standard microscopic examination. The precision profile, LoB, LoD, LoQ, and carryover were also evaluated. 6100  5900  5700  5500  5300  5100  4900  4700  4500  4300  4100  3900  3700  3500  3300  3100  2900  2700  2500  2300  2100  1900  1700  1500  1300  1100  900  700  500  300  100  -100  -300 WBC count/uL (manual microscopy) 9900  9600  9300  9000  8700  8400  8100  7800  7500  7200  6900  6600  6300  6000  5700  5400  5100  4800  4500  4200  3900  3600  3300  3000  2700  2400  2100  1800  1500  1200  900  600 5700  5500  5300  5100  4900  4700  4500  4300  4100  3900  3700  3500  3300  3100  2900  2700  2500  2300  2100  1900  1700  1500  1300  1100  900  700  500  300  100  - 8400  8100  7800  7500  7200  6900  6600  6300  6000  5700  5400  5100  4800  4500  4200  3900  3600  3300  3000  2700  2400  2100  1800  1500  1200  900  600 peritonitis. 2, 12 Similarly, ascitic fluids with a WBC count >1000/μL or a PMN cell count >250/μL, suggest spontaneous bacterial peritonitis. 1, 3, 12, 17 Also in pleural effusions, cell count is helpful to determine the differential diagnoses between transudates (WBC<1000/μL) and exudates (WBC>1000/μL). 4 Predominance of neutrophils indicates acute inflammation, while lymphocyte-predominant effusion (>50%)
suggests pleural malignancy or tuberculosis.
4,12,18,19
Manual method for cell count in a counting chamber using standard and alternative (e.g. Turk or Samson) staining solutions for microscopic evaluation are frequently used in clinical laboratory practice. 20, 21 The main advantage of using alternative staining solutions with lysing reagent that destroys the RBC membrane is to prevent possible interference in the WBC count, leaving stained nucleated cells intact for microscopic evaluation. The main disadvantage is the possible error in the WBC count due to the dilution factor added. In any case, the quality and morphology of cells can be observed in all counting chamber methods subjected to the experience of the observer with the well known limitations described in the introduction of this paper. In this regard, our results suggest that BC-6800 can be a suitable alternative to perform automated analysis for the WBC count as it showed interchangeable results with the microscopic method. Moreover, our experience shows that it is a device that displays a great practicability and this implies an advantage over microscopic counting for many reasons: fast, accurate, and reproducible results and fewer pre-analytical sample treatments. 8 In line with this, no sample preparation is needed prior to analysis in the BC-6800. It takes about <2 minutes to switch from the blood mode to the BF mode (includes automatic rinse cycles and background check) and only takes 1 minute to process a sample. However, the positive bias that BC-6800 presents in the PMN cell count implies that differential count should be carefully evaluated. The authors consider that automated differential analysis may be enough for ascitic fluid due to the elevated AUC with high sensitivity and specificity that we have obtained at the 250 PMN/ μL threshold. 1 We also obtained an elevated AUC with high sensitivity, specificity, and concordance between the automatic and microscopic methods in our series of peritoneal and pleural fluids. Nevertheless, we cannot assure the same result in other series of patients because the PMN/uL cut-off could be different from that obtained in our series since it depends on the WBC count (PMN=50%WBC). As a result, in these types of fluids it might be of interest to complete the automatic WBC count with the smear review to ensure an accurate differential count.
Similarly to our result obtained by BC-6800, a PMN positive bias count has been previously reported in other automated analyzers. One possible explanation for these results is loss of cells during centrifugation or deterioration at room temperature, particularly labile neutrophils, which may generate a different PMN enumeration. 5, 8, 22 Another feature to consider when analyzing serous fluids in automated devices with the body fluid mode is the use of gating strategies to 2720  2560  2400  2240  2080  1920  1760  1600  1440  1280  1120  960  800  640  480  320  160  0 exclude tissue cells from WBC count. 8, 22 According to previous reports hematology devices that use cell count fluorescent methods categorize macrophages as high fluorescent (HF) cells. 5, 22 Nevertheless, these cells can be included in MN count if their fluorescence intensity is not so high. 5 In this regard, our results indicated that BC-6800 includes macrophages in the WBC count since we included macrophages in the chamber count to obtain the agreement data presented herein (Passing-Bablok results showed proportional bias for BC-6800 when we excluded macrophages from the manual method in all body fluid types. Data not shown).
We observed a slight bias for the ascitic WBC count according to a previous report. 13 However our results showed a constant bias, while
Lippi et al. 13 indicated a proportional bias. The difference found between the manual and automatic methods for the ascitic WBC count and the discrepancy with the results of Lippi et al. 13 Performance data from the BC-6800 suggest that this device is adequate for clinical management of serous and CAPD fluids, since the carryover (<0.05%) and LoB (3 cells/μL) were according to the manufacturer's specifications. LoQ (8 cells/μL) presented negligible differences with previous report that may be explained by the different power regression equation generated by using different samples 14 and the CV at the 100 and 1000 cell/μL thresholds (i.e. 3%-5%) were similar to previous report. 14 In conclusion, although microscopic evaluation still remains the cornerstone in the workup of serous fluids, automated analysis is needed not only to obtain accurate results, but also to process samples within the required time. In line with this, the BC-6800 analyzer provides acceptable results for the clinical management of serous fluids.
In order to confirm our results, further studies should include a large number of samples for each body fluid type.
